Vanda Pharmaceuticals (VNDA) Net Shares Issued and Repurchased (2010 - 2018)
Analysis
Vanda Pharmaceuticals (VNDA) Net Shares Issued and Repurchased (2010 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Vanda Pharmaceuticals | 327.03 Mn | 157.00 Mn | 46.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 437,500.00 |
| Dec 31, 2017 | 643,000.00 |
| Mar 31, 2017 | 592,750.00 |
| Dec 31, 2016 | 866,011.00 |
| Mar 31, 2016 | 749,511.00 |
| Dec 31, 2015 | 1.06 Mn |
| Mar 31, 2015 | 459,000.00 |
| Dec 31, 2014 | 1.32 Mn |
| Mar 31, 2014 | 165,340.00 |
| Dec 31, 2013 | 1.25 Mn |
| Mar 31, 2013 | 197,214.00 |
| Dec 31, 2012 | 846,000.00 |
| Dec 31, 2011 | 26,764.00 |
| Dec 31, 2010 | 471,957.00 |